InsiderTrades

Form 4 for SRPT Sarepta Therapeutics, Inc.

Accepted 2023-03-08 00:00:00 ET · period of report 2023-03-06 · accession 0001209191-23-017407 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-03-08 2023-03-06 SRPT Rodino-Klapac Louise CSO, Head of R, D A - Grant $0.00 +4,500 71.1K +7% $0
D 2023-03-08 2023-03-06 SRPT Rodino-Klapac Louise CSO, Head of R, D F - Tax $157.21 -1,134 66.6K -2% -$178.3K
D 2023-03-08 2023-03-06 SRPT Rodino-Klapac Louise CSO, Head of R, D A - Grant $0.00 +27.0K 27.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-06 A A 4,500 $0.00 71,082 D — — (F2) The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date.
2 Common Common Stock 2023-03-06 F D 1,134 $157.21 66,582 D — — (F1) Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021.
3 Derivative Stock Option (right to buy) 2023-03-06 A A 27,000 $0.00 27,000 D $155.99 · 2024-03-06 to 2033-03-06 27,000 Common Stock (F3) Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.